Key pointsPercy Herrera-Añazco, MD, MeD1,2, Benoit Mougenot, PhD3,4, Jerry K. Benites-Meza5,6, Luz C. Barturén-Alvarado7,8, Carlos J. Zumarán-Nuñez6,8, Maria A. Boyd-Gamarra7,8, Fernando M. Runzer-Colmenares, MD, MSc9, Vicente A. Benites-Zapata, MD, MSc2,10
1Facultad de Ciencias de la Salud, Universidad Privada del Norte, Trujillo, Peru
2Red Internacional en Salud Colectiva y Salud Intercultural, Mexico City, Mexico
3Facultad de Ciencias Empresariales, Universidad San Ignacio de Loyola, Lima, Peru
4Centro de Excelencia en Investigaciones Económicas y Sociales en Salud, Universidad San Ignacio de Loyola, Lima, Peru
5Sociedad Científica de Estudiantes de Medicina de la Universidad Nacional de Trujillo, Trujillo, Peru
6Grupo Peruano de Investigación Epidemiológica, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru
7Escuela Profesional de Medicina Humana de la Universidad Señor de Sipán, Chiclayo, Peru
8Asociación Científica de Estudiantes de Medicina de la Universidad Señor de Sipán, Chiclayo, Peru
9Universidad Científica del Sur, Facultad de Ciencias de la Salud, Carrera de Medicina Humana, CHANGE Research Working Group, Lima, Peru
10Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, PeruDOI: https://doi.org/10.5770/cgj.26.631
ABSTRACT
Background
Older adults are a particularly vulnerable group to drug use and self-medication. The aim of the study was to evaluate self-medication as a factor associated with the purchase of brand-name and over-the-counter (OTC) drugs in older adults in Peru.
Methods
A secondary analysis was performed using an analytical cross-sectional design of data from a nationally representative survey from 2014 to 2016. The exposure variable was self-medication, defined as the purchase of medicines without a prescription. The dependent variables were purchases of brand-name and OTC drugs, both as a dichotomous response (yes/no). Information of sociodemographic variables, health insurance, and the types of drugs purchased by the participants was collected. Crude prevalence ratios (PR) were calculated and adjusted using generalized linear models of the Poisson family, considering the complex sample of the survey.
Results
In this study, 1,115 respondents were evaluated, with a mean age of 63.8 years and a male proportion of 48.2%. The prevalence of self-medication was 66.6%, while the proportions of purchases of brand-name and OTC drugs were 62.4% and 23.6%, respectively. The adjusted Poisson regression analysis revealed an association between self-medication and the purchase of brand-name drugs (adjusted PR [aPR]=1.09; 95% confidence interval [CI]: 1.01–1.19). Likewise, self-medication was associated with the purchase of OTC medications (aPR=1.97; 95%CI: 1.55–2.51).
Conclusions
This study evidenced a high prevalence of self-medication in Peruvian older adults. Two-thirds of the surveyed people bought brand-name drugs, whereas one-quarter bought OTC drugs. Self-medication was associated with a greater likelihood of buying brand-name and OTC drugs.
Key words: health of the elderly, aged, pharmacies, self-medication, drugs, generic, nonprescription drugs, Peru
Self-medication may be associated with adverse effects.
We evidenced a high prevalence of self-medication in Peruvian older.
Two-thirds bought brand-name drugs, while one-quarter bought over-the-counter drugs.
In Peruvian older, self-medication was associated with a greater likelihood of buying the brand-name and over-the-counter drugs.
Aging is a complex phase that includes loss of function, reduced autonomy, and increased morbidity. For older adults, medication is a crucial instrument for maintaining and recovering health.(1,2) However, this population group is subject to polypharmacy due to dysfunctions in different organs caused by aging. This condition increases the probability of adverse effects, mainly if self-medication potentially affects its functional capacities.(3–5)
Self-medication is defined as the use of medications without a prior medical prescription to treat symptoms and self-perceived or identified diseases by a family member6. Various types of self-medication have been identified as follows: nonprescription drugs, drug refills, drug recommendations to friends and family, the use of leftover drugs from previous prescriptions, or altering the dose of prescription drugs.(6) Self-medication also involves the use of traditional home remedies, nutritional supplements, or the use of over-the-counter (OTC) pharmaceutical products,(6–9) which despite being authorized in most countries, may also be associated with adverse effects.(10,11)
Older adults are a particularly vulnerable group to drug use and self-medication. Pharmacology in older adults experiences changes due to aging, like changes in the distributions of muscle mass, fat, and body water; the alteration of liver and kidney metabolism, which hinders the elimination of metabolites; and accumulation of toxic substances,(12) in addition to the interaction of comorbidities.(13) Therefore, the inappropriate prescription of drugs represents a public health problem, given the association with morbidity and the costs of managing adverse reactions.(5) Several studies have shown that self-medication in older adults is a frequent practice worldwide. However, its frequency and characteristics vary depending on national health systems.(14–16)
In Peru, the drug market is highly concentrated and insufficiently regulated.(17) Likewise, the pharmaceutical industry presents high expenses in promoting and advertising products and encourages self-medication with brand-name drugs through stimuli,(18) representing a problem in a country where access to medicines in health centers is ineffective.(19) As observed in the world,(20,21) self-medication in the general population in Peru is frequent. A study showed that the prevalence of inappropriate self-medication was 51%, and was associated with the male sex, ages >40 years, and not having health insurance.(22) As well as this research, other studies have evaluated self-medication with antibiotics and among pregnant women, even during the pandemic;(23–26) however, self-medication and drug consumption patterns in older adults have not been studied. Considering the demographic transition process in Peru, the proportion of older adults increased from 5.7% in 1950 to 12.7% in 2020,(27) reinforcing the interest to study this phenomenon in this growing vulnerable population. Therefore, the objectives of this study was to report the prevalence of self-medication, describe the practices of using brand-name and OTC drugs, and evaluate self-medication as a factor associated with the purchase of brand-name and OTC drugs in older adults in Peru.
A secondary analysis of data from the fourth questionnaire survey of the National Health User Satisfaction Survey from 2014 to 2016 (ENSUSALUD) of the National Institute of Statistics and Informatics of Peru (INEI) and National Superintendence of Health of Peru (SUSALUD) was conducted. ENSUSALUD was a nationally representative survey designed to collect information on health service provider institutions (IPRESS) through the information provided by the users and providers of these services. The IPRESS are public, private, or mixed institutions whose objective is the provision of health services. These can be polyclinics, medical centers, doctor’s offices, clinical laboratories, etc.
The study population was composed of people aged ≥15 years who bought some medicine for themselves, their partner, or their child in a pharmacy or drugstore close to IPRESS nationwide. The sampling was conducted in 181 IPRESS by using a probabilistic, stratified, and two-stage selection method.
The primary sampling units, namely the IPRESS of the Ministry of Health and regional governments, the social health insurance system in Peru (EsSalud), the health-care system of the armed forces and police, and the private sector clinics, were randomly selected. The secondary unit was the users of drugstores and pharmacies, who were selected in a non-probabilistic manner for convenience. Twenty-five strata corresponding to the 25 political regions of Peru were established, based on which expansion factors were estimated. However, the inference was limited to the care provided in outpatient medical consultations of IPRESS in the country.
The fourth questionnaire survey of the ENSUSALUD from 2014 to 2016 included 11,610 surveyed users. However, users who bought medications for their children or partners, those aged <60 years, and those with missing data in some variables of interest were excluded. Thus, the final sample size was 1,115 participants, representing an expanded population of 355,351 people (Figure 1).
|
| ||
|
FIGURE 1 Flowchart of the selection of participants included in the analysis, ENSUSALUD 2014–2016 | ||
Two outcomes were considered. First, the use of brand-name drugs was defined as the purchase of at least one brand-name drug. Second, the use of OTC drugs was defined as the purchase of at least one OTC drug. Both variables were constructed from information obtained from the Health Registry of Pharmaceutical Products (https://www.digemid.minsa.gob.pe/rsProductosFarmaceuticos/). In Peru, all drugs are authorized by the Ministry of Health. These are marketed according to the name that identifies them, as a brand and generic drugs. Brand-name drugs use a name assigned by a pharmaceutical company, while generic drugs have the same name as the active ingredient in the drug. On the other hand, the condition of sales, such as controlled sales and OTC medications, refers to the need to have a prescription or not. Likewise, according to the Peruvian legislation, the health professionals capable of issuing a medical prescription are doctors, dentists, and obstetricians. Two authors independently coded these variables, and discrepancies were resolved with a third author.
Self-medication was operationalized, considering the participants who bought drugs without a prescription and those who did not show the prescription at the survey time.(22) The confounding variables, according to the literature, were sex, age, educational level, language (Spanish or Quechua/other), health insurance (yes or no), type of institution (drugstore, pharmacy), and geographic region of residency (Metropolitan Lima, other areas of Coast region, Highlands, and Jungle).
ENSUSALUD is a free open-access database and belonging to the SUSALUD service, which is available at http://portal.susalud.gob.pe/blog/category/base-de-datos/. All potential participants gave their verbal consent to participate in the survey. No identification was recorded on the identity of each participant to guarantee the confidentiality of the information provided by the participants. As Peru has established only regulation for the execution of clinical trials,(28) with a gap for observational studies, international regulations govern these studies. Therefore, as a secondary analysis of open-access data without identifiers and following the international regulations, this study was exempt from review by an ethics committee.
ENSUSALUD data corresponding to 2014, 2015, and 2016 were downloaded in SPSS format (IBM SPSS Statistics, Armonk, NY), exported, and analyzed with STATA v15.0 (TX, StataCorp LP). All sampling patterns were analyzed according to stratum and weighting factor, taking into account the complex sampling design of ENSUSALUD, using the “svy” command.
In the descriptive analysis, the categorical variables were expressed in frequencies and percentages with their respective 95% confidence intervals (CIs). The numerical variables were presented as mean values with their 95% CIs. The chi-square test with Rao-Scott correction for complex sampling was used to determine whether significant differences existed between the independent variables according to the proposed outcomes. The Wald test was used to determine the differences between the numerical variables. Statistical significance was set at a p value < .05.
To determine the association between self-medication and the outcomes of interest, generalized linear models of the Poisson family were constructed, reporting prevalence ratios (PR) with their respective 95% CIs. The first model was a crude bivariate regression, while the second model was adjusted for confounding variables according to an epidemiological approach.(22) The variance inflation factors were determined to evaluate collinearity.
The prevalence of self-medication in older adults was 66.6%. The proportions of purchases of brand-name and OTC drugs were 62.4% and 23.6%, respectively. Furthermore, of the participants, 51.8% were women, 33.8% resided in Metropolitan Lima, and 47.3% had higher educational levels. The mean age of the participants was 68.3 years (95%CI: 67.9–68.7). In addition, 76.8% of the participants had health insurance, and 88% bought their medications in pharmacies (Table 1).
TABLE 1 General characteristics of the elderly users of drugstores and pharmacies, ENSUSALUD 2014–2016 (n = 1,115; N = 355,351)
Statistically significant differences in self-medication were found between the drug groups. Higher proportions of self-medication were found among the users of gastrointestinal drugs (12.2% vs. 5.8%; p<.001) and analgesics/antipyretics/corticosteroids (28.8% vs. 22.1%; p=.005). By contrast, the proportions of self-medication with antibiotics (15.1% vs. 19.4%; p=.039), for neurological pathologies (4.5% vs. 8.7%; p=.005), and with other drugs (13.2% vs. 21.6%; p<.001) were lower. In addition, the highest proportion of participants who self-medicated resided in Jungle, while the lowest proportion were those from the Highlands region (Table 2).
TABLE 2 General characteristics of the elderly users of drugstores and pharmacies according to self-medicationa
The most frequently acquired medications were analgesics/antipyretics/corticosteroids (26.6%), nonsteroidal anti-inflammatory drugs (NSAIDs; 26.1%) and antibiotics (16.6%; Table 3). Some drugs were more likely to be purchased as brand-name rather than generic drugs, such as analgesics/antipyretics/corticosteroids (32.9% vs. 16.1%; p<.001), NSAIDs (28.3% vs. 22.5%; p=.002), nutritional supplements (10.6% vs. 4.0%; p<.001), antihistamines or those for respiratory diseases (10.0% vs. 5.6%; p=.003), and other medications (19.9% vs. 9.6%; p<.001). By contrast, the drugs that were less likely to be purchased as brand-name drugs were antiparasitics/antivirals/antifungals (2.2% vs. 4.2%; p=.003) and those for cardiac pathologies (6.4% vs. 25.9%; p<.001; Table 3). Likewise, the drugs that were more likely to be purchased as OTC drugs were analgesics/antipyretics/corticosteroids (35.4% vs. 23.8%; p<.001), nutritional supplements (18.2% vs. 5.0%; p<.001), gastrointestinal drugs (15% vs. 8.6%; p<.001), and antihistamines or those for respiratory diseases (12.3% vs. 7.1%; p=.011). By contrast, the probabilities of buying OTC drugs for cardiac pathologies (7.4% vs. 15.7%; p=.002), antiparasitics/antivirals/antifungals (1.0% vs. 3.5%; p=.022), drugs for metabolic disorders (1.0% vs. 5.3%; p<.001), and antibiotics (0.9% vs. 21.4%; p<.001) were lower (Table 3).
Table 3 Types of medicine purchased by the elderly according to the use of brand-name and over-the-counter drugsa
The proportion of brand-name drug purchases was higher in the participants who resided in Metropolitan Lima (68.7%), but lowest among those from the jungle region (58.7%; p<.05). On the other hand, the proportion of purchases of brand-name medicines was lower among those who had health insurance (59.8% vs. 70.7%; p=.002). Likewise, the proportion of brand-name medicine purchases among those who self-medicated was higher. However, it only had marginal statistical significance (63.9% vs. 59.2%; p=.074; Table 4). In the analysis according to the use of OTC medicines, self-medication was associated with a greater purchase of OTC medicines (28.1% vs. 14.5%; p<.001). Similarly, those who bought OTC medicines were older on average (69.7 years vs. 67.9 years; p=.001) and were more likely to have health insurance (25.2% vs. 18.1%; p=.026; Table 4).
TABLE 4 General characteristics of elderly users of drugstores and pharmacies according to the use of brand-name and over-the-counter drugsa
The crude analysis did not reveal statistically significant differences between self-medication and the purchase of brand-name drugs (PR=1.08; 95%CI: 0.99–1.18; p=.086). However, in the adjusted analysis, the association became statistically significant (PR=1.09; 95%CI: 1.01–1.19; p=.033). On the other hand, the crude analysis revealed a greater probability of purchasing OTC drugs among the participants who self-medicated than among those who did not self-medicate (PR=1.95; 95%CI: 1.52–2.49; p<.001). In the adjusted analysis, the association remained statistically significant (PR=1.97; 95%CI: 1.55–2.51; p<.001; Table 5).
TABLE 5 Crude prevalence ratio and adjustment for the use of brand-name and over-the-counter drugs according to self-medication in older adults
Additionally, we evaluated the differences between OTC drugs and brand-name drugs. We found that eight out of 10 OTC medications were brand-name (81.50% vs. 18.50%). Only six of 10 controlled sale drugs were brand-name (57.73% vs. 42.27%). These differences were statistically significant.
The present findings show that two of three Peruvian older adults self-medicated, two of three bought brand-name drugs, and one of four bought OTC drugs. Self-medication varied according to the type of medication, being more frequent for gastrointestinal medications and analgesics/antipyretics/corticosteroids. Likewise, the purchase of brand-name medications varied according to the type of medication, being more frequent for analgesics/antipyretics/corticosteroids, NSAIDs, nutritional supplements, antihistamines or drugs for respiratory pathologies, and other medications. As well, the most purchased OTC medications were analgesics/antipyretics/corticosteroids, nutritional supplements, gastrointestinal medications, and antihistamines or drugs for respiratory pathologies. Thus, an association was observed between self-medication and the higher probability of buying brand-name and OTC medicines in older adults in Peru.
The frequency of self-medication in older adults has been increasing, as observed in other countries. For example, a study using microdata from the European Survey of Health Interviews (2006–2009) showed that the prevalence of self-medication in older European adults was 26.3%, although with significant variations between countries, reaching 49.4% in Poland but only 7.8% in Spain.(14) Furthermore, a systematic review of studies published up to 2014 found that the prevalence of self-medication in older adults worldwide ranged from 4 to 87%.(15)
On the contrary, the prevalence of self-medication in older adults in the present study was lower than that in a Brazilian study which found a prevalence of 80.5% in older adults who attended a referral hospital.(16) These differences may be related to various factors, including the year of evaluation, representativeness of the sample, and definition of self-medication. For example, in the systematic review, the mean prevalence of self-medication was 38%. However, various criteria were used to measure self-medication, where some studies identified periods of up to one year, increasing the probability of self-medication or memory biases in older adults over a longer period.(15) Similarly, the frequency of self-medication may vary depending on the health systems and the probability that they meet the needs of the insured. This study did not monitor older adults, but only assessed self-medication on the basis of whether a medical prescription was presented during the purchase of medicines in drugstores and pharmacies in Peru.
In Peru, although the population covered by health insurance increased from 60.5% to 76.4% between 2008 and 2017,(29) a study that included a national representative sample showed that 30.6% of the population had ineffective access to the medications prescribed by their treating physicians in the pharmacies of the health establishments covered by their medical insurance.(19) In Peru, this may explain the increase in the average out-of-pocket expenditure on drugs from USD 8.14 in 2007 to USD 9.68 in 2016.(30)
Older adults are most affected by ineffective access to medicines, which probably also explains the 56.5% out-of-pocket expenses for health care in 2017.(31) Therefore, the Peruvian government should consider self-medication as a problem considering its adverse effects in older adults(5) and economic effects in this often economically vulnerable population.
The increase in health insurance coverage has not been homogeneous. Universal health insurance represents >40% of the insurance coverage nationwide. This coverage in the Jungle region has not changed significantly from 2009 to 2017.(29) In addition, the region is more likely to have ineffective access to medicines.(19) This antecedent could explain the present finding in this region that showed a higher probability of self-medication. Similarly, people from this region have problems accessing intercultural health services, despite the advances made to address this issue in the country,(32) limiting the access of Quechua-speaking patients even though they have health insurance.
Though with some similarities, the type of drugs also varies between countries. In Brazil, the most widely used drugs for self-medication were centrally acting muscle relaxants, analgesics and antipyretic agents, NSAIDs, and antirheumatic drugs.(14) In the systematic review that included studies from various countries, including Latin American and Caribbean countries such as Brazil and Mexico, it was found that the most frequent medications were analgesics and antipyretics, followed by anti-inflammatory drugs, cardiovascular agents, dietary supplements, and alternative medicine components.(15) These differences may be related to differences in the burden of diseases in the countries and to the sensitivity, severity, perceived barriers, and patient educational levels, as suggested by some authors.(33) Similarly, the type of drug varies depending on other aspects not evaluated in this research, such as depression, functional dependence, recent hospitalization, activity restriction, and physical inactivity.(15)
The findings from this study indicate that although older adults with health insurance buy brand-name drugs, this may be related to the perception of the efficacy of these drugs in the study population. A nationwide study in Peruvian hospitals showed that 46.7% of the participants agreed that generic drugs are less effective than brand-name drugs, and 49.3% have recommended using generic drugs to other people.(34) Even people with the lowest income in Metropolitan Lima hold this perception. A study of the acceptance of generic drugs by users from the low-income sectors of Metropolitan Lima showed that, despite the high consumption of generic drugs, this acceptance was linked more to economic capacity than to trust toward this type of medication, as there are doubts about its safety and efficacy.(35)
These results are a cause for concern when the public market for medicines represents 71% of the national market and where increasing access to generic medicines has been proposed as a strategy to improve access to medicines in Peru.(36) However, in spite of the possible mistrust, the annual evolution of generic prescription drug sales has demonstrated a progressive increase globally since 2010, and the strategies for their acceptance have been successful.(37)
The prices of drugs vary according to the type of pathology, and this variation could explain the more frequent use of generics for cardiovascular diseases in this study. For example, in 2019, the brand-name box of Enalapril 10 mg with 30 tablets cost USD 2.9, while the prices of the same box of generics with an international nonproprietary name ranged from USD 0.7 to 2.(38)
Self-medication is not always considered as a negative behavior when practiced using OTC drugs. Therefore, it can signify a sign of self-care that emphasizes the role of each individual in their health care.(7) However, the list of supply OTC drugs varies by country, and the patterns of their use may depend on national health insurance systems and regulations. For example, in the UK and many other European countries, OTC drugs are only available in pharmacies where they are dispensed at the pharmacist’s discretion and only in small amounts. The list of OTC medications is established by the General Directorate of Medicines, Supplies, and Drugs, which also supervises the compliance with their supply.(39)
In this study, a quarter of older adults self-medicated with OTC. On the contrary, a Brazilian study showed that 52.6% of older adults self-medicated.(16) The most widely used OTC medications were analgesics/antipyretics/corticosteroids, nutritional supplements, gastrointestinal medications, and antihistamines or drugs for respiratory pathologies. OTC medications are usually considered to have fewer adverse effects than prescription medication drugs. However, recent studies have warned about the risks associated with their use. In France, a study investigated the main adverse drug reactions by using data from a pharmacovigilance database and found that they were mainly caused by NSAIDs, analgesics, and benzodiazepines.(40) A multicenter study that covered an area of hospital influence found that NSAIDs mainly caused adverse reactions in adults who self-medicated with OTC medications, and most adverse drug reactions occurred in women aged 70 to 79 years and men aged 60 to 69 years during the period from 2000 to 2008.(41) Moreover, pharmacists documented problems related to medications, of which the most common were those reported with the use of NSAIDs and analgesics.(42)
On the other hand, a 2015 study found that in the United States, around half of all adults had used at least one dietary supplement in the past month.(43) This translates into a lucrative industry, with an estimated 40 billion USD for this country alone,(44) even though vitamin supplements have shown no clinical benefits in the general population.(45) A study in 63 emergency departments in the United States found that 2,154 hospitalizations between 2004 and 2013 were due to adverse effects of nutritional supplements.(43) Among older adults, pill-induced asphyxia or dysphagia accounted for 37.6% of all emergency visits for adverse events related to nutritional supplements. The use of micronutrients was involved in 83.1% of these visits.(43)
The potential risk from self-medication to which older adults are exposed is evident. Thus, interventions and public policies must be developed to integrate the commitments of those involved, the health insurance system, and pharmacies. Thus, this study highlights one of the potential interventions that have been developed to reduce the frequency of harmful self-medication in older adults. Integrated care for older people (iCOPE) is a proposal for care adapted to older adults at different levels of care.(46) In addition, the iCOPE nursing manual proposes educational interventions such as self-care practices, self-medication, and promotion of continence and health examinations.(47) Therefore, the involvement of older adults in their medical care could substantially reduce various health complications related to self-medication.
In Peru, health insurance coverage increased among patients over 65 at 21.2%, from 2009 to 2017, with the consequent increase in the probability of seeking medical care.(29) Despite the improvement in health coverage, monetary poverty in this population still limits access to health services, which, together with distrust,(48) promotes self-medication.(49,50) Additionally, problems in the supply of medicines in health facilities are a problem that affects all Peruvians,(51) even more than older adults, whose average pocket expenditure for 2017 was more than USD 180, and even more for those who suffer from chronic diseases.(31) These problems, together with distrust in generic drugs, require policies that improve drug supply in health facilities in the country and improve trust in generic drugs.(34) Some strategies for the first point have been suggested that include the programming and acquisition of strategic drugs in the Pan American Health Organization (PAHO) according to the prioritized population.(36) Likewise, strategies for financing according to programming, and coordination with regional governments and health institutions to ensure distribution and application throughout the sector.(36) Finally, strengthen execution monitoring mechanisms throughout the sector.(36) Regarding improving confidence in generic drugs, PAHO proposes to develop a comprehensive strategy that includes appropriate regulation; promotion of the marketing of generic drug lists of essential drugs, and promotion of extended use of the international common denomination.(52) Additionally, PAHO suggests guaranteeing the quality of all medicines marketed; establishment of economic incentives for the supply and demand of generic drugs; development of mechanisms of acceptance of generic medicines between health professionals and society; and the promotion of prescription by generic name and responsible substitution in pharmacies.(52)
Our results showed that the majority of OTC drugs were brand-name. Therefore, strategies must also be directed towards the regulation and availability of more OTC and non-OTC medicines that are generic medicines in order to reduce out-of-pocket costs when there is no access to health insurance.
This study has limitations. First, as a secondary analysis, questions pre-established in the survey were used for the study variables. However, these questions have been elaborated by experts from the National Institute of Statistics and Informatics of Peru. Likewise, the formulation of the ENSUSALUD questions required a period of validation and adaptation to the Peruvian population. Second, as a cross-sectional study, the evaluation of the association between self-medication and the proposed outcomes is not necessarily causal. However, the study design allowed assessment of this association with adjustment for potential confounding factors, following an epidemiological model. Third, selection bias might have resulted from the inclusion of patients who went to pharmacies, even though selecting the first sampling unit was probabilistic. Finally, some variables, such as family members at home, comorbidities, and cognitive impairment, could be addressed in future research to better understand self-medication and the purchase of brand-name and OTC drugs.
Self-medication was present in two-thirds of the Peruvian older adults in this study. A quarter of them bought OTC drugs, and two-thirds bought brand-name drugs. Self-medication with gastrointestinal medications and analgesics/antipyretics/corticosteroids was more frequent. Analgesics/antipyretics/corticosteroids, NSAIDs, nutritional supplements, antihistamines/respiratory pathologies, and other medications were the most purchased brand-name medications. At the same time, the most purchased OTC drugs were analgesics/antipyretics/corticosteroids, nutritional supplements, gastrointestinal medications, and antihistamines or drugs for respiratory pathologies. Thus, self-medication with brand-name and OTC drugs was more likely in the older adults in Peru.
Not applicable.
We have read and understood the Canadian Geriatrics Journal’s policy on disclosing conflicts of interest and declare that we have none.
This research did not receive external funding
1 Nordin Olsson I, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011 Nov 3;9(1):1–9. Available from: http://www.hqlo.com/content/9/1/95
2 Lutz BH, Miranda VIA, Bertoldi AD. Potentially inappropriate medications among older adults in Pelotas, Southern Brazil. Rev Saude Publica. 2017 Jun 22;51:52. Available from: http://www.rsp.fsp.usp.br/
3 Cesari M. How polypharmacy affects frailty [Internet]. Expert Rev Clin Pharmacol. 2020;13(11):1179–81. Available from: https://doi.org/10.1080/17512433.2020.1829467
4 Carmona-Torres JM, Cobo-Cuenca AI, Recio-Andrade B, Laredo-Aguilera JA, Martins MM, Rodríguez-Borrego MA. Prevalence and factors associated with polypharmacy in the older people: 2006–2014. J Clin Nurs. 2018 Aug 1;27(15–16):2942–52. Available from: https://pubmed.ncbi.nlm.nih.gov/29603814/
5 Locquet M, Honvo G, Rabenda V, Van Hees T, Petermans J, Reginster JY, et al. Adverse health events related to self-medication practices among elderly: a systematic review [Internet]. Drug Aging. 2017;34:359–65. Available from: https://link.springer.com/article/10.1007/s40266-017-0445-y
6 World Health Organization. Guidelines for the regulatory assessment of medicinal products for use in self-medication. Geneva: WHO; 2002. Available from: https://apps.who.int/iris/handle/10665/66154
7 Mortazavi SS, Shati M, Khankeh HR, Ahmadi F, Mehravaran S, Malakouti SK. Self-medication among the elderly in Iran: a content analysis study. BMC Geriatr. 2017 Sep 1;17(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580436/
8 Bennadi D. Self-medication: a current challenge. J Basic Clin Pharm. 2014;5(1):19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012703/
9 Chouhan K, Prasad SB. Self-medication and their consequences: a challenge to health professional. Asian J Pharm Clin Res. 2016;9(2):314–17. Available from: https://innovareacademics.in/journals/index.php/ajpcr/article/view/10675
10 Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self medication [Internet]. Drug Safety. 2001;24(14):1027–37. Available from: https://pubmed.ncbi.nlm.nih.gov/11735659/
11 Ruiz M. Risks of self-medication practices. Curr Drug Safety. 2010 Aug 19;5(4):315–23. Available from: https://pubmed.ncbi.nlm.nih.gov/20615179/
12 Rozenfeld S. [Prevalence, associated factors, and misuse of medication in the elderly: a review] [in Portugese]. Cadernos de saúde pública. 2003;19(3):717–24.
13 Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions [Internet]. BMC Geriatrics. 2017;17(1):1–10. Available from: https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-017-0621-2
14 Brandão GR, Teixeira L, Araújo L, Paúl C, Ribeiro O. Self-medication in older European adults: prevalence and predictive factors. Arch Gerontol Geriatr. 2020 Jul 21;91. Available from: https://pubmed.ncbi.nlm.nih.gov/32717589/
15 Jerez-Roig J, Medeiros LF, Silva VA, Bezerra CL, Cavalcante LA, Piuvezam G, et al. Prevalence of self-medication and associated factors in an elderly population: a systematic review [Internet]. Drug Aging. 2014;31:883–96. Available from: https://link.springer.com/article/10.1007/s40266-014-0217-x
16 de Oliveira SB, Barroso SC, Bicalho MA, Reis AM. Profile of drugs used for self-medication by elderly attended at a referral center. Einstein. 2018 Nov 29;16(4):eAO4372. Available from: https://www.scielo.br/j/eins/a/LJfXBXtzy8tFpK4LG4RLbwG/?lang=en
17 Valverde JL. Latin American pharmaceutical overview. Pharma Pol Law. 2014;16(3–4):179–206.
18 Pillaca Medina ML, Carrión Domínguez K. Automedicación en personas adultas que acuden a boticas del Distrito Jesús Nazareno, Ayacucho 2015. An Fac Med. 2016;77(4):387. Available from: http://www.scielo.org.pe/pdf/afm/v77n4/a11v77n4.pdf
19 Mezones-Holguín E, Solis-Cóndor R, Benites-Zapata VA, Garnica-Pinazo G, Marquez-Bobadilla E, Tantaleán-Del-águila M, et al. Institutional differences in the ineffective access to prescription medication in health care centers in Peru: analysis of the National Survey on User Satisfaction of Health Services (ENSUSALUD 2014). Rev Peru Med Exp Salud Publica. 2016 Apr 1;33(2):205–14. Available from: https://pubmed.ncbi.nlm.nih.gov/27656918/
20 Domingues PH, Galvão TF, de Andrade KR, de Sá PT, Silva MT, Pereira MG. Prevalence of self-medication in the adult population of Brazil: a systematic review [Internet]. Rev Saude Publica. 2015;49:36. Available from: https://www.scielo.br/j/rsp/a/KKtXwhTQD3mLLdh7FRw6qtL/?lang=en
21 Chang J, Wang Q, Fang Y. Socioeconomic differences in self-medication among middle-aged and older people: data from the China health and retirement longitudinal study. BMJ Open. 2017 Dec 1;7(12):e017306. Available from: https://bmjopen.bmj.com/content/7/12/e017306
22 Urrunaga-Pastor D, Benites-Zapata VA, Mezones-Holguín E. Factors associated with self-medication in users of drugstores and pharmacies in Peru: an analysis of the National Survey on User Satisfaction of Health Services, ENSUSALUD 2015. F1000Research. 2020 Jan 24;8:23. Available from: https://doi.org/10.12688/f1000research.17578.1
23 Rojas-Adrianzén C, Pereyra-Elías R, Mayta-Tristán P. [Prevalence and factors associated with over-the-counter antimicrobial purchases, Peru 2016][in Spanish]. Rev Peru Med Exp Salud Publica. 2018 Sep 11;35(3):400–08. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/3458/3117
24 Miní E, Varas R, Vicuña Y, Lévano M, Rojas L, Medina J, et al. [Self-medication behavior among pregnant women user of the Instituto nacional Materno Perinatal, Peru 2011] [in Spanish]. Rev Peru Med Exp Salud Publica. 2012;29(2):212–17. Available from: https://pubmed.ncbi.nlm.nih.gov/22858767/
25 Hernández-Vásquez A, Alarcon-Ruiz CA, Díaz-Seijas D, Magallanes-Quevedo L, Rosselli D. Purchase of medications without prescription in Peru: a cross-sectional population-based study. F1000Research. 2019 Feb 22;7:1392. Available from: https://f1000research.com/articles/7-1392
26 Inostroza-Ruiz LA, Gutiérrez-Elescano PI, Bautista-Cruz N, Apesteguia-Infantes JA, Jáuregui-Maldonado JF, Tapia-Manrique ER, et al. [Perceptions of self-medication of the population, during the covid-19 pandemic in Peru] [in Spanish]. Rev del Cuerpo Med Hosp Nac. 2021 Dec 31;14(4):479–83. Available from: http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1451
27 Carhuavilca Bonett D, Sánchez Aquila A, Hidalgo Calle N, Guitiérrez Espino C, Mendoza Loyola D, Ruiz Calderon R. Situación de la población adulta mayor. INEI. 2020;2(2):1–55. Available from: https://www.inei.gob.pe/media/MenuRecursivo/boletines/informe-tecnico-poblacion-adulta-mayor.pdf
28 Instituto Nacional de Salud (INS). Reglamento de Ensayos Clínicos [Internet]. Lima, Perú: INS; 2018. Available from: https://ensayosclinicos-repec.ins.gob.pe/en/
29 Mezones-Holguín E, Amaya E, Bellido-Boza L, Mougenot B, Murillo JP, Villegas-Ortega J, et al. [Health insurance coverage: the Peruvian case since the universal insurance act] [in Spanish]. Rev Peru Med Exp Salud Publica. 2019 Jun 1;36(2):196–206. Available from: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342019000200005&lng=es&nrm=iso&tlng=es
30 Hernández-Vásquez A, Vargas-Fernández R, Magallanes-Quevedo L, Bendezu-Quispe G. Análisis del gasto de bolsillo en medicamentos e insumos en Perú en 2007 y 2016. Medwave. 2020 Mar 19;20(2):e7833. Available from: https://www.medwave.cl/link.cgi/Medwave/Revisiones/Analisis/7833.act
31 Hernández-Vásquez A, Rojas-Roque C, Santero M, Prado-Galbarro FJ, Rosselli D. [Health-related out-of-pocket expenses in older Peruvian adults: analysis of the national household survey on living conditions and poverty 2017] [in Spanish]. Rev Peru Med Exp Salud Publica. 2018 Sep 26;35(3):390–99. Available from: https://pubmed.ncbi.nlm.nih.gov/30517498/
32 Berríos PC, Icaza IG. Derechos de los pueblos indígenas en el Perú. Cartilla 1: Los pueblos indígenas y sus derechos. Lima, Peru: Derecho, Ambient y Recur Nat – DAR; 2018; Available from: https://www.dar.org.pe/wp-content/uploads/2018/06/Cartilla-1-Derechos-de-los-pueblos-indigenas-aprobada-14_05_18_R.pdf
33 Sadeghian Motavali Z, Abedi H, Davaridolatabadi E. Self-medication and its effective modifiable factors among elderly referred health care centers in Shahr-e-Kord in 2015. Electron Physician. 2016 Nov 25;8(11):3205–13. Available from: https://pubmed.ncbi.nlm.nih.gov/28070253/
34 Mendoza-Chuctaya G, Cubas-Llalle WS, Mejia CR, Chachaima-Mar JE, Montesinos-Segura R, Arce-Villalobos LR, et al. [The population’s perceptions of generic drugs compared to original brand-name drugs in Peruvian hospitals] [in Spanish]. Cad Saude Publica. 2019;35(10). Available from: https://www.scielo.br/j/csp/a/7RqxcKJhYjTGKHfX8xSVykv/?lang=es&format=pdf
35 Canales M, Loly F, Rumiche JV. Acceptance of generic drugs by users from sector C, D and E sectors in three zones of Lima. Cienc Invest. 2012;15(1):9–14.
36 Ugarte Ubilluz O. Estrategias para mejorar el acceso a medicamentos en el Perú. An Fac Med. 2019;80(1):104–08. Available from: https://doi.org/10.15381/anales.v80i1.15878
37 Aranda M, Rosasco MA. La farmacia de los medicamentos genéricos. Rev Colomb Ciencias Químico-Farmacéuticas. 2019 May 1;48(2):357–71. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0034-74182019000200357
38 García E. Medicamentos genéricos: mira la diferencia de precios con los de marca [Internet]. Agencia Peruana de Noticias Andina. 2019. Available from: https://andina.pe/agencia/noticia-medicamentos-genericos-mira-diferencia-precios-con-de-marca-772152.aspx
39 Dirección General de Medicamentos Insumos y Drogas (DIGEMID)[Internet]. Available from: https://www.digemid.minsa.gob.pe/303
40 Berreni A, Montastruc F, Bondon-Guitton E, Rousseau V, Abadie D, Durrieu G, et al. Adverse drug reactions to self-medication: a study in a pharmacovigilance database. Fundam Clin Pharmacol. 2015 Oct 1;29(5):517–20. Available from: https://pubmed.ncbi.nlm.nih.gov/26215671/
41 Schmiedl S, Rottenkolber M, Hasford J, Rottenkolber D, Farker K, Drewelow B, et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. Drug Safety. 2014 Apr 1;37(4):225–35. Available from: https://link.springer.com/article/10.1007%2Fs40264-014-0141-3
42 Ylä-Rautio H, Siissalo S, Leikola S. Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications. Int J Clin Pharm. 2020 Apr 1;42(2):786–95. Available from: https://link.springer.com/article/10.1007%2Fs11096-020-00984-8
43 Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015 Oct 15;373(16):1531–40. Available from: https://pubmed.ncbi.nlm.nih.gov/26465986/
44 The Lancet. Dietary supplement regulation: FDA’s bitter pill [Internet]. The Lancet. 2019;393(10173):718. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30406-4/fulltext
45 Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER. Enough is enough: stop wasting money on vitamin and mineral supplements [Internet]. Ann Intern Med. 2013;159(12):850–51. Available from: https://www.acpjournals.org/doi/10.7326/0003-4819-159-12-201312170-00011
46 World Health Organization. Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity [Internet]. Geneva: World Health Organization; 2017. Available from: https://apps.who.int/iris/handle/10665/258981
47 World Health Organization. Integrated care for older people (ICOPE): a manual for nurses (trainee’s handbook) [Internet]. New Delhi, India: World Health Organization, Regional Office for South-East Asia; 2020. Available from: https://apps.who.int/iris/handle/10665/333290
48 Arroyo J, Velásquez A, Céspedes S, Malo M, Pedroza J, Alexandro Saco, et al. La Salud Hoy: Problemas y Soluciones. CENTRUM Graduate Business School. Lima; 2015.
49 Ministerio de la Mujer y Poblaciones Vulnerables. PLANPAM 2-13–2017. Plan nacional para los adultos mayores. Lima, Peru: Ministerio de la Mujer y Poblaciones Vulnerables; 2013. p. 70.
50 Ministerio de desarrollo e Inclusión social (MIDIS). Manual de operaciones del programa nacional de asistencia solidaria “Pensión 65” [Internet]. Lima, Peru: MIDIS; 2012. p. 102. Available from: https://www.peru.gob.pe/docs/planes/14183/plan_14183__2012.pdf
51 Herrera-Añazco P, Valenzuela-Rodríguez G, Torres-Pesantes L, Toro-Huamanchumo CJ. [Shortage of antidiabetic and antihypertensive in the context of the initial stage of the COVID-19 pandemic in Peru] [in Spanish]. Rev del Cuerpo Med Hosp Nac. 2021 Oct 30;14(Sup1):22–27. Available from: http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1152
52 Organización Panamericana de la Salud. Guía para la implementación de estrategias de medicamentos genéricos en los países de América Latina y el Caribe como mecanismo para mejorar el acceso a medicamentos. Washington, DC: OPS; 2010.
Canadian Geriatrics Journal, Vol. 26, No. 1, March 2023